Kidney Function Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Urine Tests, Blood Test, Others), By Component (Dipsticks, Reagents, Kits & Assays, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region and Competition

The International Diabetes Atlas' tenth edition estimates that 537 million adults (20-79 years old), or one in ten people, had diabetes in 2021. It is anticipated that this number will increase to 643 million by 2030 and 783 million by 2045..

Rising Prevalence of Kidney Disorders and Diseases

. Furthermore, acute kidney injury (AKI), also known as acute renal failure or acute kidney injury, is very common in patients who are in hospitals. Acute kidney injury (AKI) affects more than 13 million people and results in 1.7 million deaths every year across the globe.

Technological Advancements

Rising adoption of advanced technology concerning diagnosis and treatment is expected to bolster the growth of the market. These continuous developments and innovations are providing better treatments to patients.

Increase in the Prevalence of Diabetes and Hypertension

According to the Centers for Disease Control and Prevention (CDC), in 2019, there are approximately 37.3 million people who have diabetes, accounting for 11.3% of the US population. Out of these, 28.7 million people are diagnosed, and 8.5 million people are undiagnosed.

Recent Developments

• In 2019, Fresenius Medical Care received breakthrough devicedesignation by the U.S. FDA for its most recent hemodialysis machine, whoseobjective is to stop blood clotting without using any medication
• Similarly, in 2019, CareDx announced the new model built for kidneytransplants. It has included Predicted artificial intelligence (AI) forindividuals who are suffering from chronic kidney diseases (CKD).
• Recently, in 2022, bioMérieux received United States Food and DrugAdministration (US FDA) authorization for the innovative VIDAS NEPHROCHECKassay to detect kidney stress in individuals who are at risk of acute kidneyinjury (AKI).

Download Free Sample Report

Market Segmentation

In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising cases of renal disorders.

Market Players

Baxter International Inc., Abbott Laboratories, Inc., Sysmex Corporation., F. Hoffmann-La Roche Ltd., Danaher Corporation., URIT Medical Electronic Co. Ltd., Nova Biomedical Corporation., Laboratory Corporation of America Holdings., Siemens Healthineers., ARKRAY Inc., IDEXX Laboratories, Inc., Fresenius SE & Co. KGaA., Cook Group., ACON Laboratories, Inc, and Randox Laboratories Ltd.